Draft:Equashield

Equashield is a global privately held medical device company. It is focused on protecting healthcare workers from hazardous drug exposure by developing automated compounding robots and Closed system drug transfer devices. Its products are sold in over 25 countries across 5 continents and are the most used CSTD in the United States.

History
Equashield was founded by Eric Shem-Tov and Marino Kriheli in 2009.

The company was established with the aim of developing a new generation of closed-system drug transfer devices (CSTDs) to address the safety concerns associated with handling hazardous drugs in healthcare settings.

Equashield Opened $30 Million Manufacturing Facility in 2019.

in 2020, Equashield sold 25% stake to Nordic Capital at $1.3 billion valuation.

EQUASHIELD CSTD
The fully encapsulated Syringe Units prevents the exposure to syringe plunger and barrel contamination caused by hazardous drug handling.

Syringe Units
The system is equipped with a built-in closed pressure equalization with sterile air. The connector is permanently bonded onto the syringe body preventing accidental disconnections and house shielded needles to prevent the risk of accidental needle sticks.

Vial adaptors
Vial Adaptor firmly snaps onto a standard vial with a unique mechanism that prevents angled or non-centered spiking. The vial adaptor provides a safe and contamination-free vial access port for the Syringe Unit.

The vial adaptor’s elastomeric membrane serves a dual purpose; to serve as a microbial barrier preventing microbial ingress, remaining drug residue-free for up to 10 repeated connections in 7 days.

Spike adaptors
Spike adaptors are designed to firmly connect between any standard IV bag and tubing set, enabling the safe transfer of medication dose into the IV Bag. Considering variations among various IV Bag manufacturers

The SA-W is designed for safe and cost-effective withdrawal of diluent for reconstitution with the Syringe Units (SU). Designed also to work in conjunction with FC-180 to cost-effectively administer multiple consecutive medications to a patient while maintaining a closed system.

EQUASHIELD PRO
EQUASHIELD® Pro is an automated compounding robot. Utilizing CSTD.

Unlike traditional robot’s reliance on robotic arms that mimic human motion with the use of conventional needle and syringe methods, which may potentially lead to cytotoxic drips, spills, aerosols and vapor release, EQUASHIELD Pro uses a multi-station compounding approach to minimize both the motion and time it takes to prepare a dose, much like a factory manufacturing line.

EQUASHIELD® Pro is designed to make the adoption of robotics simple and affordable in the IV compounding workspace. It is comparable in size to a standard Biological Safety Cabinet, making it easy to fit into hospital pharmacies.